Daratumumab plus carfilzomib: An optimistic approach in relapsed/refractory multiple myeloma

Background: Although with the introduction of novel agents, clinical outcomes have significantly improved in patients of multiple myeloma (MM); however, nearly all relapse, requiring subsequent treatment. Patients who have been heavily treated for relapsed/refractory MM (RRMM) have limited options a...

Full description

Saved in:
Bibliographic Details
Main Authors: A P Dubey, Sameer Khatri, Sachin Maggo, Nilabh K Singh, Durgesh Sharma
Format: Article
Language:English
Published: Thieme Medical and Scientific Publishers Pvt. Ltd. 2020-01-01
Series:Indian Journal of Medical and Paediatric Oncology
Subjects:
Online Access:http://www.ijmpo.org/article.asp?issn=0971-5851;year=2020;volume=41;issue=6;spage=846;epage=849;aulast=Dubey
Tags: Add Tag
No Tags, Be the first to tag this record!